Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that a previously-thought resolved manufacturing issue persists. The move lower wiped out...
Covered in this story
What has happened since
- Stryker Corporation is up 8.5% since this was published, 33 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Stryker Corporation
- Truist Securities: $278 → $310 by Oct 2027 · Hold via Investing.com
- Needham: $278 → $418 by Oct 2027 · Buy via Investing.com
- Stifel: $275 → $330 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $SYK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Stryker Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.